Medtronic (MDT) Cash from Investing Activities (2014 - 2026)

Medtronic (MDT) has 13 years of Cash from Investing Activities data on file, last reported at -$917.0 million in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 87.14% year-over-year to -$917.0 million; the trailing twelve-month figure through Apr 2026 stood at -$2.9 billion (down 51.47% YoY), and the FY2026 full-year result was -$2.9 billion, down 51.47% from the prior year.
• Cash from Investing Activities eased to -$917.0 million in Q2 2026, from -$816.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $271.0 million in Q2 2022 to a low of -$1.6 billion in Q3 2022.
• A 5-year average of -$605.3 million and a median of -$514.5 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 84.24% in 2022 and plunged 275.28% in 2023, its largest moves.
• Tracing MDT's Cash from Investing Activities over 5 years: stood at -$1.1 billion in 2022, then jumped by 63.0% to -$424.0 million in 2023, then grew by 18.63% to -$345.0 million in 2024, then plunged by 39.71% to -$482.0 million in 2025, then sank by 90.25% to -$917.0 million in 2026.
• Business Quant data shows MDT's Cash from Investing Activities at -$917.0 million in Q2 2026, -$816.0 million in Q1 2026, and -$482.0 million in Q4 2025.